Cargando…
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
[Image: see text] Nonalcoholic steatohepatitis (NASH) is the fastest growing cause of hepatocellular carcinoma (HCC) in the United States. Changes in N-glycosylation on specific glycosites of serum proteins have been investigated as potential markers for the early detection of NASH-related HCC. Here...
Autores principales: | Lin, Yu, Zhu, Jianhui, Zhang, Jie, Dai, Jianliang, Liu, Suyu, Arroyo, Ana, Rose, Marissa, Singal, Amit G., Parikh, Neehar D., Lubman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261276/ https://www.ncbi.nlm.nih.gov/pubmed/35811936 http://dx.doi.org/10.1021/acsomega.2c02600 |
Ejemplares similares
-
PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021) -
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022) -
Discovery of Core-Fucosylated Glycopeptides as Diagnostic
Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023) -
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
por: Trinchera, Marco, et al.
Publicado: (2017) -
Analysis of Serum Haptoglobin
Fucosylation in Hepatocellular
Carcinoma and Liver Cirrhosis of Different Etiologies
por: Zhu, Jianhui, et al.
Publicado: (2014)